These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38610602)

  • 1. Personalized Assessment of Mortality Risk and Hospital Stay Duration in Hospitalized Patients with COVID-19 Treated with Remdesivir: A Machine Learning Approach.
    Ramón A; Bas A; Herrero S; Blasco P; Suárez M; Mateo J
    J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610602
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of Machine Learning in Hospitalized Patients with Severe COVID-19 Treated with Tocilizumab.
    Ramón A; Zaragozá M; Torres AM; Cascón J; Blasco P; Milara J; Mateo J
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study.
    Mengato D; Mazzitelli M; Francavilla A; Bettio M; Sasset L; Presa N; Pivato L; Lo Menzo S; Trevenzoli M; Venturini F; Gregori D; Cattelan AM
    Clin Exp Med; 2023 Oct; 23(6):2749-2756. PubMed ID: 36961678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with moderate to severe COVID-19 outcomes on remdesivir according to baseline 4C mortality score.
    Sellers J; Chang J; Jones J; Hintze TD
    Pulm Pharmacol Ther; 2023 Feb; 78():102188. PubMed ID: 36603741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remdesivir for the treatment of COVID-19.
    Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014962. PubMed ID: 34350582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Treatment with Remdesivir and 30-day Hospital Readmissions in Patients Hospitalized with COVID-19.
    Finn A; Jindal A; Andrea SB; Selvaraj V; Dapaah-Afriyie K
    Am J Med Sci; 2022 May; 363(5):403-410. PubMed ID: 35151637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remdesivir Treatment Lacks the Effect on Mortality Reduction in Hospitalized Adult COVID-19 Patients Who Required High-Flow Supplemental Oxygen or Invasive Mechanical Ventilation.
    Huang C; Lu TL; Lin L
    Medicina (Kaunas); 2023 May; 59(6):. PubMed ID: 37374231
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir for the treatment of COVID-19.
    Grundeis F; Ansems K; Dahms K; Thieme V; Metzendorf MI; Skoetz N; Benstoem C; Mikolajewska A; Griesel M; Fichtner F; Stegemann M
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014962. PubMed ID: 36695483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparative Study of Antiretroviral (Lopinavir/Ritonavir) and Remdesivir Used in the Pandemic in Iraq on the Clinical Outcome in Patients with SARS-CoV-2.
    Alabdalaali MM; Hadi AM
    Arch Razi Inst; 2023 Jun; 78(3):935-941. PubMed ID: 38028857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.
    Lee S; Santarelli A; Caine K; Schritter S; Dietrich T; Ashurst J
    J Am Osteopath Assoc; 2020 Dec; 120(12):926-933. PubMed ID: 33136164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-life use of remdesivir-containing regimens in COVID-19: a retrospective case-control study.
    Cogliati Dezza F; Oliva A; Mauro V; Romani FE; Aronica R; Savelloni G; Casali E; Valeri S; Cancelli F; Mastroianni CM
    Infez Med; 2022; 30(2):211-222. PubMed ID: 35693052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of obesity and dyslipidemia on Remdesivir effectiveness in hospitalized patients with SARS-CoV-2-related pneumonia: An observational study.
    Tumminia A; Romano R; Brugaletta G; Scicali R; Biondi G; Oliveri R; Romano M; San Lio PM
    Nutr Metab Cardiovasc Dis; 2022 Jul; 32(7):1635-1641. PubMed ID: 35508458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different COVID-19 treatments' impact on hospital length of stay.
    Iwamoto S; Muhar BK; Chen H; Chu H; Johnstone M; Sidhu A; Chu H; Fischer J; Chu G
    Eur J Med Res; 2023 Jul; 28(1):218. PubMed ID: 37400927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients.
    Piñana JL; Heras I; Aiello TF; García-Cadenas I; Vazquez L; Lopez-Jimenez J; Chorão P; Aroca C; García-Vidal C; Arroyo I; Soler-Espejo E; López-Corral L; Avendaño-Pita A; Arrufat A; Garcia-Gutierrez V; Arellano E; Hernández-Medina L; González-Santillana C; Morell J; Hernández-Rivas JÁ; Rodriguez-Galvez P; Mico-Cerdá M; Guerreiro M; Campos D; Navarro D; Cedillo Á; Martino R; Solano C;
    Viruses; 2023 Oct; 15(10):. PubMed ID: 37896843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
    Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
    JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Improvement, Outcomes, Antiviral Activity, and Costs Associated With Early Treatment With Remdesivir for Patients With Coronavirus Disease 2019 (COVID-19).
    Wong CKH; Lau KTK; Au ICH; Xiong X; Lau EHY; Cowling BJ
    Clin Infect Dis; 2022 Apr; 74(8):1450-1458. PubMed ID: 34265054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of remdesivir on SARS-CoV-2 viral dynamics and mortality in viraemic patients hospitalized for COVID-19.
    Hagman K; Hedenstierna M; Widaeus J; Arvidsson E; Hammas B; Grillner L; Jakobsson J; Gille-Johnson P; Ursing J
    J Antimicrob Chemother; 2023 Nov; 78(11):2735-2742. PubMed ID: 37757451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine Learning as a Precision-Medicine Approach to Prescribing COVID-19 Pharmacotherapy with Remdesivir or Corticosteroids.
    Lam C; Siefkas A; Zelin NS; Barnes G; Dellinger RP; Vincent JL; Braden G; Burdick H; Hoffman J; Calvert J; Mao Q; Das R
    Clin Ther; 2021 May; 43(5):871-885. PubMed ID: 33865643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital length of stay for severe COVID-19: implications for Remdesivir's value.
    Anderson M; Bach P; Baldwin MR
    medRxiv; 2020 Aug; ():. PubMed ID: 32817960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.